Biofrontera (BFRIW) Stock Price, Quote, News & History

Biofrontera Inc (BFRIW) Stock Price, Quote, News & History

BFRIWNASDAQ

Trade with Public

$0.0679

At close: Feb 27, 4:00 PM EST

$0.0500

-0.0179-26.36%

After Hours: Jan 21, 4:24 PM EST

Key Statistics

Open

Volume / Avg.

0 / 2.06K

Day Range

- - -

52 Wk Range

0.03 - 0.28

Market Cap

$74.62K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

41.77

Recent Biofrontera Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.00M

Investing Cash Flow (TTM)

-4.00K

Financing Cash Flow (TTM)

12.55M

Free Cash Flow (TTM)

-12.01M

Capital Expenditure (TTM)

-4.00K

Net Change in Cash (TTM)

544.00K

Valuation Metrics

Enterprise Value

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$4.46M

LT Debt

$4.46M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$3.42M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 2.06K

Day Range

- - -

52 Wk Range

0.03 - 0.28

Market Cap

$74.62K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

41.77

About

Sector

Health Care

Industry

Pharmaceuticals

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which incl...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Biofrontera (BFRIW) stock?

You can purchase shares of Biofrontera (NASDAQ:BFRIW) through any online brokerage.

View our list of the best stock brokerages

Who are Biofrontera (BFRIW) competitors?

Other companies in Biofrontera’s space includes: Akanda Corp (NASDAQ:AKAN), InMed Pharmaceuticals Inc (NASDAQ:INM), Universe Pharmaceuticals Inc (NASDAQ:UPC), NRX Pharmaceuticals Inc (NASDAQ:NRXPW) and Aspire Biopharma Holdings Inc (NASDAQ:ASBPW).

What is the forecast, or price target, for Biofrontera (BFRIW) stock?

There is no analysis for Biofrontera to provide a consensus price target.

What is the current price for Biofrontera (BFRIW)?

The stock price for Biofrontera (NASDAQ: BFRIW) is $0.05 last updated January 21, 2026 at 4:24 PM EST.

Does Biofrontera (BFRIW) pay a dividend?

There are no upcoming dividends for Biofrontera.

When is Biofrontera (NASDAQ:BFRIW) reporting earnings?

Biofrontera does not have any upcoming earnings scheduled.

Is Biofrontera (BFRIW) going to split?

There is no upcoming split for Biofrontera.

What sector and industry does Biofrontera (BFRIW) operate in?

Biofrontera is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Akanda Corp

NASDAQ:AKAN

$0.91

InMed Pharmaceuticals Inc

NASDAQ:INM

$0.85

Universe Pharmaceuticals Inc

NASDAQ:UPC

$3.00

NRX Pharmaceuticals Inc

NASDAQ:NRXPW

$0.05

Aspire Biopharma Holdings Inc

China SXT Pharmaceuticals Inc

NASDAQ:SXTC

$2.41

CNS Pharmaceuticals Inc

NASDAQ:CNSP

$2.97

Key Statistics

Open

Volume / Avg.

0 / 2.06K

Day Range

- - -

52 Wk Range

0.03 - 0.28

Market Cap

$74.62K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

41.77

Recent Biofrontera Inc News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.00M

Investing Cash Flow (TTM)

-4.00K

Financing Cash Flow (TTM)

12.55M

Free Cash Flow (TTM)

-12.01M

Capital Expenditure (TTM)

-4.00K

Net Change in Cash (TTM)

544.00K

Valuation Metrics

Enterprise Value

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$4.46M

LT Debt

$4.46M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$3.42M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 2.06K

Day Range

- - -

52 Wk Range

0.03 - 0.28

Market Cap

$74.62K

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

41.77

About

Sector

Health Care

Industry

Pharmaceuticals

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry